Company Oncotime Srl with Fiscal Code 36037957
recorded a turnover of 2024 of
116.730,
with a net profit of
96.812
and having an average number of employees of
1.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Oncotime Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
7.351
41.377
58.080
146.925
97.116
107.743
124.149
145.204
116.730
Total Income - EUR
-
7.351
41.385
62.616
151.726
99.967
107.959
124.609
146.071
116.847
Total Expenses - EUR
-
1.191
1.500
5.997
10.589
10.299
10.652
12.240
14.355
16.951
Gross Profit/Loss - EUR
-
6.160
39.884
56.619
141.136
89.668
97.308
112.369
131.716
99.896
Net Profit/Loss - EUR
-
5.940
38.643
54.863
139.660
88.748
96.251
111.226
130.293
96.812
Employees
-
0
0
0
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -19.2%, from 145.204 euro in the year 2023, to 116.730 euro in 2024.
The Net Profit decreased by -32.753 euro, from 130.293 euro in 2023, to 96.812 in the last year.
Check the financial reports for the company - Oncotime Srl
Financial Rating - ONCOTIME SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Oncotime Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Oncotime Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Oncotime Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
142.891 euro in 2024 which includes Inventories of
0 euro, Receivables of
3.153 euro and cash availability of
139.738 euro.
The company's Equity was valued at
96.861 euro, while total Liabilities amounted to
46.030 euro.
Equity decreased by -32.753 euro, from 130.342 euro in 2023, to 96.861 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Oncotime Srl